drugset / Trial / NCT03594175
Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy and safety of CUSA-081 (diluted reteplase) in the restoration of central venous access device (CVAD) functionality in participants 18 years and older.
Timeline
- Start
- 2020-02-12
- Primary completion
- 2023-06-08
- Completion
- 2023-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alteplase | Protein / enzyme biologic | 2 mg/ml | Other |
| Subject | reteplase | Protein / enzyme biologic | 0.7 mg | Other |